Presidents:

Lee L. Swanström (USA-France)

Jie He (China)

Michio Hongo (Japan)

 

OESO Website

  < back to the Program at a glance

Session 41

 

Monday, September 4
4:15 – 6:15 pm

Room 2

 

 

Eosinophilic esophagitis

 

Chairs: Roberto Penagini (Italy) – Alain Schopfer (Switzerland)

Discussant: Edoardo Savarino (Italy)

 

  • What is the current definition of EoE?
  • What is the current incidence of EoE in children and adults?
  • EoE in children and adults: two different diseases?
  • What did we learn from genetic studies in EoE? Carine Blanchard (Nestlé, Switzerland)
  • What can the allergist add for EoE management?
  • What causes symptoms in EoE? Roberto Penagini (Italy)
  • Can we discriminate histologically EoE from PPI-REE and GERD?
  • Are there additional histological markers besides peak eosinophil count in histological assessment of EoE?
  • Serum periostin as a biomarker for diagnostic and monitoring of EoE.
  • What are the long-term consequences of untreated EoE?
  • What are the treatment endpoints for EoE? Alain Schoepfer (Switzerland)
  • What is the efficacy of PPI in the long-term run?
  • What is the clinical, endoscopic and histologic efficacy of swallowed topical steroids in EoE?
  • Are biologic therapies effective in EoE?
  • Which elimination diet works best for EoE treatments?
  • Can EoE patients solely be treated by periodic esophageal dilations?
  • What is the relationship between EoE and HP infection?
  • PPI responsive esophageal eosinophilia, or PPI responsive EoE? Roberto Penagini (Italy)

 

 

 

 

  Top

 

©2016 OESO – SYMPORG SA            webdesign www.architecturevisualdesign.ch